Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Adagio Medical Holdings ( (ADGM) ) is now available.
Adagio Medical Holdings, Inc. has scheduled its 2026 Annual Meeting of Stockholders for June 16, 2026, with the specific time and location to be disclosed in its forthcoming definitive proxy statement. The company has set April 24, 2026, as the record date for determining stockholders entitled to receive notice of, and vote at, the annual meeting.
The company has also established April 30, 2026, as the key deadline for stockholders to submit proposals for inclusion in the proxy materials, nominate directors, or bring other business before the meeting, provided they comply with Rule 14a-8, its bylaws, and the SEC’s universal proxy rules. These steps clarify the timeline and procedural requirements for shareholder participation and proxy contests ahead of the 2026 meeting, signaling a formal framework for governance engagement in the coming proxy season.
The most recent analyst rating on (ADGM) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Adagio Medical Holdings stock, see the ADGM Stock Forecast page.
Spark’s Take on ADGM Stock
According to Spark, TipRanks’ AI Analyst, ADGM is a Neutral.
The score is held back primarily by weak financial performance (minimal revenue, sustained losses, and ongoing cash burn with elevated leverage). Technicals are a key offset with price trending above major moving averages and positive momentum, while valuation remains constrained by losses (negative P/E). A positive FDA IDE trial expansion supports the outlook but does not yet change near-term financial risk.
To see Spark’s full report on ADGM stock, click here.
More about Adagio Medical Holdings
Adagio Medical Holdings, Inc. operates as a publicly held corporation, with its securities registered under the Securities Exchange Act of 1934 and its governance structured through amended and restated bylaws. The company is headquartered at 26051 Merit Circle, Suite 102, Laguna Hills, California, and is subject to U.S. Securities and Exchange Commission proxy and disclosure rules for its stockholder meetings.
Average Trading Volume: 98,621
Technical Sentiment Signal: Hold
Current Market Cap: $31.76M
Learn more about ADGM stock on TipRanks’ Stock Analysis page.